<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Volgograd State Medical University</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Volgograd State Medical University</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Волгоградского государственного медицинского университета</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-9480</issn><issn publication-format="electronic">1994-9499</issn><publisher><publisher-name xml:lang="en">Volgograd State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">139196</article-id><article-id pub-id-type="doi">10.19163/1994-9480-2022-19-4-170-180</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">FETAL GROWTH RESTRICTION: BEST PRACTICES FOR DIAGNOSIS, MONITORING AND TREATMENT (CLINICAL RECOMMENDATION)</article-title><trans-title-group xml:lang="ru"><trans-title>ЗАДЕРЖКА РОСТА ПЛОДА: ПЕРЕДОВАЯ ПРАКТИКА ПО ДИАГНОСТИКЕ, МОНИТОРИНГУ И ЛЕЧЕНИЮ (КЛИНИЧЕСКИЙ ПРОТОКОЛ)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shklyar</surname><given-names>A. L</given-names></name><name xml:lang="ru"><surname>Шкляр</surname><given-names>А. Л</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры акушерства и гинекологии, Институт непрерывного медицинского и фармацевтического образования, Волгоградский государственный медицинский университет; заместитель главного врача, Волгоградский областной клинический перинатальный центр № 2</p></bio><email>vokpc2@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tkachenko</surname><given-names>L. V</given-names></name><name xml:lang="ru"><surname>Ткаченко</surname><given-names>Л. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заведующий кафедрой акушерства и гинекологии, Институт непрерывного медицинского и фармацевтического образования</p></bio><email>tkachenko.fuv@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Verovskaya</surname><given-names>T. A</given-names></name><name xml:lang="ru"><surname>Веровская</surname><given-names>Т. А</given-names></name></name-alternatives><bio xml:lang="ru"><p>главный врач, Волгоградский областной клинический перинатальный центр № 2, главный внештатный акушер-гинеколог Комитета здравоохранения Волгоградской области</p></bio><email>vokpc2@volganet.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Volgograd State Medical University</institution></aff><aff><institution xml:lang="ru">Волгоградский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Volgograd regional clinical perinatal center</institution></aff><aff><institution xml:lang="ru">Волгоградский областной клинический перинатальный центр</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2022</year></pub-date><volume>19</volume><issue>4</issue><issue-title xml:lang="en">VOL 19, NO4 (2022)</issue-title><issue-title xml:lang="ru">ТОМ 19, №4 (2022)</issue-title><fpage>170</fpage><lpage>180</lpage><history><date date-type="received" iso-8601-date="2023-01-26"><day>26</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Shklyar A.L., Tkachenko L.V., Verovskaya T.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Шкляр А.Л., Ткаченко Л.В., Веровская Т.А.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Shklyar A.L., Tkachenko L.V., Verovskaya T.A.</copyright-holder><copyright-holder xml:lang="ru">Шкляр А.Л., Ткаченко Л.В., Веровская Т.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/1994-9480/article/view/139196">https://journals.eco-vector.com/1994-9480/article/view/139196</self-uri><abstract xml:lang="en"><p>Worldwide, fetal growth restriction (FGR) is a leading cause of stillbirth, neonatal mortality, and short- and long-term morbidity. Ongoing advances in clinical care, especially in definitions, diagnosis, and management of FGR, require efforts to effectively translate these changes to the wide range of obstetric care providers. This article highlights agreements based on current research in the diagnosis and management of FGR. The purpose of this article is to provide a comprehensive summary of available evidence along with practical recommendations concerning the care of pregnancies at risk of or complicated by FGR, with the overall goal to decrease the risk of stillbirth and neonatal mortality and morbidity associated with this condition. This article is directed at multiple stakeholders, including healthcare providers, healthcare delivery organizations and providers, FIGO member societies, and professional organizations. Aspects of FGR addressed in this article include prediction, diagnosis, investigation, and management.</p></abstract><trans-abstract xml:lang="ru"><p>Во всем мире задержка роста плода (ЗРП) является ведущей причиной мертворождения, неонатальной смертности, а также ранней и поздней неонатальной и младенческой заболеваемости. Непрерывный прогресс клинической медицины, смена определений, подходов к диагностике и лечению ЗРП, требует эффективного распространения новых знаний на широкий круг специалистов, задействованных в оказании акушерской помощи. В этой статье освещаются современные критерии диагностики и подходы к мониторингу и ведению беременности, использование которых поможет значительно снизить необоснованные антенатальные потери. Эта статья предназначена для множества заинтересованных сторон, включая организаторов здравоохранения, врачей --акушеров-гинекологов, неонатологов и врачей ультразвуковой диагностики Аспекты ЗРП, рассматриваемые в этой статье, включают прогнозирование, диагностику, расследование, ведение и послеродовое консультирование.</p></trans-abstract><kwd-group xml:lang="en"><kwd>fetal growth restriction</kwd><kwd>pregnancy</kwd><kwd>postpartum counseling</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>задержка роста плода</kwd><kwd>беременность</kwd><kwd>послеродовое консультирование</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>American College of Obstetricians and Gynecologists' Committee on Practice Bulletins - Obstetrics and the Society for Maternal-Fetal Medicine. ACOG practice bulletin no. 204: fetal growth restrictions. Obstet Gynecol. 2019;133(2):e97-e109.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Melamed N., Baschat A., Yinon Y. et al. FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restriction. The International Journal of Gynecology &amp; Obstetrics. 2021. https://doi.org/10.1002/ijgo.13522.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Morris R.K., Bilagi A., Devani P., Kilby M.D. Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis. Prenatal Diagn. 2017;37(3):253-265.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Gordijn SJ., Beune I.M., Thilaganathan B. et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333-339.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Pels A., Beune I.M., van Wassenaer-Leemhuis A.G., Limpens J., Ganzevoort W. Early-onset fetal growth restriction: a systematic review on mortality and morbidity. Acta Obstet Gynecol Scand. 2020;99(2):153-166.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Francis A., Hugh O., Gardosi J. Customized vs INTERGROWTH-21(st) standards for the assessment of birth-weight and stillbirth risk at term. Am J Obstet Gynecol. 2018;218(2S):S692-S699.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hadlock F.P., Harrist R.B., Sharman R.S., Deter R.L., P a r k S.K. Estimation of fetal weight with the use of head, body, and femur measurements-a prospective study. Am J Obstet Gynecol. 1985;151(3):333-337.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Hiersch L., Lipworth H. Kingdom J., Barrett J., Melamed N. Identification of the optimal growth chart and threshold for the prediction of antepartum stillbirth. Arch Gynecol Obstet. 2021;303(2):381-390.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Salomon L.J., Alfirevic Z., Da Silva C.F. et al. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound Obstet Gynecol. 2019;53(6):715-723.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Aviram A., Sherman C., Kingdom J., Zaltz A., Barrett J., Melamed N. Defining early vs late fetal growth restriction by placental pathology. Acta Obstet Gynecol Scand. 2019; 98(3):365-373.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Smith G.C.S. Universal screening for foetal growth restriction. Best Pract Res Clin Obstet Gynaecol. 2018;49:16-28.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Khalil A., Sotiriadis A., Chaoui R. et al. ISUOG Practice Guidelines: role of ultrasound in congenital infection. Ultrasound Obstet Gynecol. 2020;56(1):128-151.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Borrell A., Grande M., Pauta M., Rodriguez-Revenga L., Figueras F. Chromosomal microarray analysis in fetuses with growth restriction and normal karyotype: a systematic review and meta-analysis. Fetal Diagn Ther. 2018;44(1):1-9.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Bakalis S., Cao K., Johal N., Cuckow P., Pandya P. The value of the routine third trimester ultrasound scan in antenatal care: Problems with guidance and outdated data in a highly technological field. Eur J Obstet Gynecol Reprod Biol. 2020;245:51-55.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Spencer R., Ambler G., Brodszki J. et al. EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction. BMC Pregnancy Childbirth. 2017;17(1):43.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Temming L.A., Dicke J.M., Stout M.J. et al. Early second-trimester fetal growth restriction and adverse perinatal outcomes. Obstet Gynecol. 2017;130(4):865-869.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Vollgraff Heidweiller-Schreurs C.A., van Osch I.R., Heymans M.W. et al. Cerebroplacental ratio in predicting adverse perinatal outcome: a meta-analysis of individual participant data. BJOG. 2021;128(2):226-235.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Zur R.L., Kingdom J.C., Parks W.T., Hobson S.R. The Placental Basis of Fetal Growth Restriction. Obstet Gynecol Clin North Am. 2020;47(1):81-98.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Levytska K., Higgins M., Keating S. et al. Placental pathology in relation to uterine artery doppler findings in pregnancies with severe intrauterine growth restriction and abnormal umbilical artery doppler changes. Am J Perinatal. 2017;34(5):451-457.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Levine T.A., Grunau R.E., McAuliffe F.M., Pinnamaneni R., Foran A., Alderdice F.A. Early childhood neurodevelopment after intrauterine growth restriction: a systematic review. Pediatrics. 2015;135(1):126-141</mixed-citation></ref></ref-list></back></article>
